Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 21

Trial Status

Recruiting1
Terminated1
Other1

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT06411210Phase 2Recruiting
Obesity Complicating Type 1 Diabetes: GLP-1 Analogue Anti-obesity Treatment
Diabetes type1Obesity
PrincipalinvestigatorStart date: 2024-07-16
NCT06105931Phase 1Active Not Recruiting
Physiologic Markers of Cardiometabolic Risk in People With Type 1 Diabetes
Obesitytype1diabetes
PrincipalinvestigatorStart date: 2023-12-13
NCT03582956Not ApplicableTerminated
Effect of Adiposity on Hepatic and Peripheral Insulin Resistance in Type 1 Diabetes
AdiposityType1 Diabetes Mellitus
PrincipalinvestigatorStart date: 2019-01-01

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT06411210Phase 2PrincipalInvestigator

Obesity Complicating Type 1 Diabetes: GLP-1 Analogue Anti-obesity Treatment

Diabetes type1Obesity
Recruiting
NCT06105931Phase 1PrincipalInvestigator

Physiologic Markers of Cardiometabolic Risk in People With Type 1 Diabetes

Obesitytype1diabetes
Active Not Recruiting
NCT03582956Not ApplicablePrincipalInvestigator

Effect of Adiposity on Hepatic and Peripheral Insulin Resistance in Type 1 Diabetes

AdiposityType1 Diabetes Mellitus
Terminated

All 3 trials loaded